HAMMAD HAFEEZ: Open Payments
NPI 1427044205 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 11 payments from 8 companies in 2025. Trend: 2023 $86 · 2024 $80 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $69 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Stryker Corporation | 2 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
Products named: REZDIFFRA, FLOWTRIEVER CATHETER, S, Rybelsus, Ozempic, XIFAXAN, JOURNAVX, GVOKE HYPOPEN, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across VA — which companies pay providers there.
